ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,271Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 19

$479K Total Retail Price of All Prescriptions

Rank: 7 out of 19

297 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 297 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 5,935 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 39.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LISINOPRIL 522 286 1 6
AMLODIPINE BESYLATE 433 323 2 3
SIMVASTATIN 365 211 3 7
METFORMIN HCL 311 191 4 26
HYDROCHLOROTHIAZIDE 270 203 5 28
OMEPRAZOLE 238 140 6 5
ALENDRONATE SODIUM 207 174 7 50
LEVOTHYROXINE SODIUM 184 141 8 4
GABAPENTIN 183 102 9 12
METOPROLOL TARTRATE 172 105 10 13
CARVEDILOL 166 121 11 23
FLUTICASONE PROPIONATE 164 97 12 45
NEXIUM 163 114 13 37
FUROSEMIDE 150 89 14 2
TRAMADOL HCL 150 105 14 16
CRESTOR 133 62 16 71
ATORVASTATIN CALCIUM 129 78 17 38
DIOVAN 125 64 18 41
POTASSIUM CHLORIDE 121 93 19 11
RANITIDINE HCL 121 105 19 17
PREDNISONE 117 73 21 63
CITALOPRAM HBR 105 74 22 15
NAPROXEN 104 69 23 120
METOPROLOL SUCCINATE 104 79 23 33
METFORMIN HCL ER 102 58 25 204
LISINOPRIL-HYDROCHLOROTHIAZIDE 95 43 26 54
PRAVASTATIN SODIUM 94 69 27 32
GLIMEPIRIDE 93 74 28 62
DIOVAN HCT 93 64 28 99
ADVAIR DISKUS 91 44 30 66
GLIPIZIDE 89 30 31 49
LANTUS 88 34 32 29
AZITHROMYCIN 81 50 33 91
INSULIN SYRINGE 73 43 34 152
TRAMADOL HCL-ACETAMINOPHEN 73 59 34 183
HYDROCODONE-ACETAMINOPHEN 71 45 S3 36 1
SPIRONOLACTONE 70 45 37 77
TAMSULOSIN HCL 69 52 38 35
MELOXICAM 69 54 38 116
CLONIDINE HCL 64 44 40 56
WARFARIN SODIUM 63 63 41 10
COMBIVENT 63 14 41 158
CYCLOBENZAPRINE HCL 59 33 R 43 113
PROAIR HFA 59 42 43 135
TRAZODONE HCL 58 22 45 20
TRIAMCINOLONE ACETONIDE 57 44 46 90
CLOPIDOGREL 56 44 47 30
ALLOPURINOL 56 21 47 64
FAMOTIDINE 56 28 47 31
LOSARTAN POTASSIUM 55 53 50 43
CIPROFLOXACIN HCL 55 47 50 74
VENTOLIN HFA 53 32 52 247
JANUVIA 52 34 53 95
AMOXICILLIN 50 28 54 128
PANTOPRAZOLE SODIUM 50 44 54 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.